| Particulars |
| Company Name |
Cohance Lifesciences Ltd |
| Face Value |
1 |
| BSE Code |
543064 |
| Year End |
202603 |
| Full Year |
| Equity (Rs in Cr.) |
38.26 |
| B.V. Rs |
117.10 |
| Sales Rs in Cr. |
2,030.50 |
| NP Rs in Cr. |
250.20 |
| NP Var% |
-8.00 |
| Div% |
0.00 |
| CPS Rs |
10.00 |
| EPS Rs |
6.50 |
| Traded Value(Rs in Lakhs) |
53.80 |
| 52 Week High |
1,121.00 |
| 52 Week Low |
268.00 |
| Price BSE |
406.00 |
| Price NSE |
405.00 |
| Market Capital(Rs in Cr.) |
15,541.79 |
| P/C Ratio |
40.50 |
| P/E Ratio |
62.10 |
| Price Vs.BV |
3.47 |
| Latest Quarter |
| Year End |
202603 |
| Sales Rs in Cr. |
567.55 |
| NP Rs in Cr. |
44.67 |
| NP Var % |
-67.00 |
| Trailing Twelve Months |
| Year End |
202603 |
| Sales |
914.50 |
| OPM |
38.79 |
| NP |
247.20 |
| NP Var% |
-7.94 |
| EPS |
6.54 |
| PE |
62.12 |
|